204 related articles for article (PubMed ID: 11599338)
21. Olfactory disturbance related to pyrazinamide.
Tsou CC; Chien JY
QJM; 2014 Mar; 107(3):217-8. PubMed ID: 24023071
[No Abstract] [Full Text] [Related]
22. Summaries for patients. Short-course treatment for latent tuberculosis is associated with more frequent liver injury than long-course treatment is.
Ann Intern Med; 2002 Oct; 137(8):I32. PubMed ID: 12379094
[No Abstract] [Full Text] [Related]
23. Fatal and severe hepatitis associated with rifampin and pyrazinamide for the treatment of latent tuberculosis infection--New York and Georgia, 2000.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2001 Apr; 50(15):289-91. PubMed ID: 11330495
[TBL] [Abstract][Full Text] [Related]
24. [Fulminant hepatitis in the course of antitubercular treatment (apropos of 2 cases)].
Mbaye PS; Talarmin F; Sane M; Eladari D; Klotz F
Dakar Med; 1995; 40(2):129-31. PubMed ID: 9827070
[TBL] [Abstract][Full Text] [Related]
25. Side effects of drugs used to treat tuberculosis.
Newton RW
Scott Med J; 1975 Mar; 20(2):47-9. PubMed ID: 47648
[No Abstract] [Full Text] [Related]
26. Inactive hepatitis B surface antigen carrier state and hepatotoxicity during antituberculosis chemotherapy.
Lee BH; Koh WJ; Choi MS; Suh GY; Chung MP; Kim H; Kwon OJ
Chest; 2005 Apr; 127(4):1304-11. PubMed ID: 15821209
[TBL] [Abstract][Full Text] [Related]
27. Hepatoxic reaction to antituberculous drugs: Adjustments to therapeutic regimen.
O'Brien RJ
JAMA; 1991 Jun; 265(24):3323. PubMed ID: 2046117
[No Abstract] [Full Text] [Related]
28. Fatal and severe hepatitis associated with rifampin and pyrazinamide for the treatment of latent tuberculosis infection--New York and Georgia, 2000.
Can Commun Dis Rep; 2001 Jul; 27(13):114-6. PubMed ID: 11443837
[No Abstract] [Full Text] [Related]
29. Rifampin plus pyrazinamide-induced hepatitis requiring hospitalization in a 30-y-old male with latent tuberculosis.
Potolidis E; Mantadakis E; Zeniodi MH; Samonis G
Scand J Infect Dis; 2005; 37(2):155-7. PubMed ID: 15773037
[TBL] [Abstract][Full Text] [Related]
30. [Adverse reactions to short-course anti-tuberculous therapy (author's transl)].
Carrasco E
Rev Med Chil; 1981 Jun; 109(6):566-72. PubMed ID: 7330536
[No Abstract] [Full Text] [Related]
31. Two-month regimen of isoniazid, rifampin and pirazinamid for latent tuberculosis infection.
Duarte R; Carvalho A; Correia A
Public Health; 2012 Sep; 126(9):760-2. PubMed ID: 22633080
[No Abstract] [Full Text] [Related]
32. From the Centers for Disease Control and Prevention. Fatal and severe hepatitis associated with rifampin and pyrazinamide for the treatment of latent tuberculosis infection--New York and Georgia, 2000.
JAMA; 2001 May 23-30; 285(20):2572-3. PubMed ID: 11396466
[No Abstract] [Full Text] [Related]
33. Gynaecomastia during antituberculosis chemotherapy with isoniazid.
Dixit R; Sharma S; Nawal CL
J Assoc Physicians India; 2008 May; 56():390-1. PubMed ID: 18700651
[No Abstract] [Full Text] [Related]
34. Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide treatment for latent tuberculosis infection.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2002 Nov; 51(44):998-9. PubMed ID: 12455909
[TBL] [Abstract][Full Text] [Related]
35. Rifampin and pyrazinamide for treatment of latent tuberculosis infection: is it safe?
Jasmer RM; Daley CL
Am J Respir Crit Care Med; 2003 Mar; 167(6):809-10. PubMed ID: 12623855
[No Abstract] [Full Text] [Related]
36. [Case of fatal liver failure due to anti-tuberculous therapy].
Harada Y; Kawakami K; Koyama K; Yamaryo T; Kimura Y
Kekkaku; 2007 Sep; 82(9):705-9. PubMed ID: 17969987
[TBL] [Abstract][Full Text] [Related]
37. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
Zierski M; Bek E
Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
[No Abstract] [Full Text] [Related]
38. [Effectiveness of tocopherol and anti-hypoxic agents in liver damage caused by antitubercular agents].
Skakun NP; Slivka IuI
Probl Tuberk; 1991; (3):57-9. PubMed ID: 1871097
[TBL] [Abstract][Full Text] [Related]
39. From the Centers for Disease Control and Prevention. Update: Fatal and severe liver injuries associated with Rifampin and Pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations--United States, 2001.
JAMA; 2001 Sep; 286(12):1445-6. PubMed ID: 11596606
[No Abstract] [Full Text] [Related]
40. From the Centers for Disease Control and Prevention. Update: fatal and severe liver injuries associated with rifampin and pyrazinamide treatment for latent tuberculosis infection.
JAMA; 2002 Dec; 288(23):2967. PubMed ID: 12492097
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
